Banyan Hill is touting Oxford Club’s Alexander Green’s story about how small caps and microcaps will outdistance outperform other stocks. The one he is pushing is a microcap selling at about $3 that uses AI to design new drugs and medicines, earning money on royalties due the company. Claims that Nvidia and Merck are partners. […]

Motley Fool has begun to aggressively tease the technology behind Apple’s “T288” project. Sounds like it may relate to a VR or AR project. Any thoughts?